FOLD - Amicus Therapeutics Inc. (FOLD) CEO John Crowley on Q2 2021 Results - Earnings Call Transcript

Amicus Therapeutics, Inc. (FOLD) Q2 2021 Earnings Conference Call August 5, 2021 08:00 ET Company Participants Andrew Faughnan - Head, Investor Relations John Crowley - Chairman and Chief Executive Officer Bradley Campbell - President and Chief Operating Officer Daphne Quimi - Chief Financial Officer Jeff Castelli - Chief Development Officer Mitchell Goldman - Chief Medical Officer Conference Call Participants Ritu Baral - Cowen Ellie Merle - UBS Kristen Kluska - Cantor Fitzgerald Anupam Rama - JPMorgan Dae Gon Ha - Stifel Andrea Tan - Goldman Sachs Yun Zhong - BTIG Gil Blum - Needham & Company Joori Park - SVB Leerink Presentation Operator Good morning, ladies and gentlemen and welcome to the Amicus Therapeutics Second Quarter 2021 Financial Results Conference Call and Webcast. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Mr. Andrew Faughnan, Head

For further details see:

Amicus Therapeutics, Inc. (FOLD) CEO John Crowley on Q2 2021 Results - Earnings Call Transcript